These empirical findings provide a mechanistic framework to explain clinical observations that HCC patients with high levels of CBX8 in tissue samples have a higher probability of exhibiting distant metastases, as well as significantly shorter overall survival rates. Here, CBX8 is linked to hepatocellular carcinoma.